L-161,982 (EP4A)   Click here for help

GtoPdb Ligand ID: 1952

Synonyms: EP4A | L-161982 | L161982
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: EP4A is a selective EP4 receptor antagonist.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 12
Topological polar surface area 139.16
Molecular weight 654.16
XLogP 7
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCc1nn(c(=O)n1Cc1ccc(cc1)c1ccccc1S(=O)(=O)NC(=O)c1ccc(s1)C)c1ccccc1C(F)(F)F
Isomeric SMILES CCCCc1nn(c(=O)n1Cc1ccc(cc1)c1ccccc1S(=O)(=O)NC(=O)c1ccc(s1)C)c1ccccc1C(F)(F)F
InChI InChI=1S/C32H29F3N4O4S2/c1-3-4-13-29-36-39(26-11-7-6-10-25(26)32(33,34)35)31(41)38(29)20-22-15-17-23(18-16-22)24-9-5-8-12-28(24)45(42,43)37-30(40)27-19-14-21(2)44-27/h5-12,14-19H,3-4,13,20H2,1-2H3,(H,37,40)
InChI Key JYZLVNVGBRFRME-UHFFFAOYSA-N
References
1. Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M, Hutchins S, Lachance N, Sawyer N, Slipetz D et al.. (2001)
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2).
Mol Pharmacol, 60 (1): 36-41. [PMID:11408598]
2. Young RN, Billot X, Han Y, Slipetz DA, Chauret N, Belley M, Metters K, Mathieu MC, Greig GM, Denis D, Girard M. (2004)
Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist.
Heterocycles, 64 (1): 437-446.